Search results
Doctors Test the Limits of What Obesity Drugs Can Fix
New York Times· 3 days ago“Obesity first” doctors say they start with one pill, to treat obesity, and often find other chronic...
New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial
Medscape· 3 days agoThe highly selective oral Janus kinase (JAK) inhibitor SHR0302 (ivarmacitinib) enables more patients...
Shoring up blood vessels may offer new approach for treating autoimmune rheumatic diseases
Medical Xpress· 4 days agoA study from physician-scientists at the Hospital for Special Surgery (HSS) points to a potential...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 2 days agoWith the arrival of biosimilar competition for its blockbuster drug Humira, AbbVie has said much of its sales growth potential lies with these two anti-inflammatories. In ...
Sjogren's Syndrome
Health· 2 days agoPeople with Sjogren’s syndrome are also at increased risk of yeast infections (candidiasis), both orally and vaginally, which may require antifungal ...
Phase 3 Trial Supports Ixekizumab in Juvenile PsA, ERA
Medscape· 2 days agoIxekizumab (Taltz), an interleukin-17A inhibitor that's already approved for the treatment of...
Joint pain at night: Causes and treatment
Medical News Today· 3 days agoJoint pain at night has several causes, including a person’s sleeping position, bedding used, and existing medical conditions, such as arthritis....
Gateway - Quartz
Quartz· 3 days agoHumira, a monoclonal antibody used to treat arthritis among other conditions, is the most lucrative drug in history. Since entering the market in 2003, ...
Baysient® Launches Therapeutic Drug Monitoring Software for Oncology Biologics
Benzinga· 3 days agoBaysient®, a leading provider of therapeutic drug monitoring (TDM) software, today announced the launch of TuMinimize™, a web-based nomogram/algorithm designed to optimize ...
Putting the brakes on chronic inflammation | Cornell Chronicle
Cornell News Service· 5 days agoThe immune system has many pathways to protect the body from infection, but sometimes an overactive...
